22
Views
46
CrossRef citations to date
0
Altmetric
Original Article

Cerebrospinal Fluid Interleukin-1 β/InterLeukin-1 Receptor Antagonist Balance and Tumor Necrosis Factor-α Concentrations in Tuberculous, Viral and Acute Bacterial Meningitis

, , &
Pages 667-674 | Received 28 Apr 1994, Accepted 22 Aug 1994, Published online: 08 Jul 2009
 

Abstract

The levels of interleukin-1β, IL-1 receptor antagonist and tumor necrosis factor-α (TNF-α) were analyzed in 19 cases of tuberculous, 14 cases of viral, and 22 cases of acute bacterial meningitis, and in 18 control subjects. 20 patients (91%) with acute bacterial and 8(42%) with tuberculous meningitis had detectable amounts of TNF-α in the initial cerebrospinal fluid (CSF) sample (mean 1044 ± 131 pg/ml, range 95–1950, and mean 61 ± 23 pg/ml, range 25–300, respectively), whereas TNF-α was not detectable in any of the patients with viral meningitis, or in any of the control subjects. IL-1β levels were 767 ± 110 pg/ml (185–2000) in acute bacterial, 345 ± 63 pg/ml (50–670) in tuberculous, 257 ± 70 pg/ml (20–700) in viral meningitis, and 37 ± 4 pg/ml (10–68) in control subjects. Il–1 receptor antagonist concentrations were significantly elevated in all meningitis groups, without significant differences between the groups. Il-1 receptor antagonist levels were 2487 ± 62 pg/ml (2250–2950) in acute bacterial, 2216 ± 82 pg/ml (1350–2550) in tuberculous and 1985 ± 92 pg/ml (650–2500) in viral meningitis, and 154 ± 26 pg/ml (20–245) in control CSF samples. A positive correlation was found between TNF and IL-1β levels (p < 0.01), and TNF levels and conscious state (p < 0.05). The ratio of concentrations of IL-1 receptor antagonist to IL-1β was 3.2 in acute bacterial meningitis, 6.9 in tuberculous meningitis and 8.3 in viral meningitis. This ratio was significantly different between the acute bacterial meningitis group and the other groups (p < 0.01), which indicates that the balance between cytokines and antagonists is of importance for the pathogenicity and diagnosis of central nervous system infections.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.